A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status
Clinical trial NCT02831842 · COMPLETED
Trial details
- NCT number
- NCT02831842
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-06-09
- Primary completion
- 2016-06-09
- Enrollment
- 4278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.